Tillman Gerngross (Craig F. Walker/The Boston Globe via Getty Images)
October 17, 2022 07:12 AM EDT
People

For­mer Till­man Gern­gross Covid-19 an­ti­body start­up cuts costs and head­count again, one month af­ter re­brand

Max Gelman

Senior Editor

The com­pa­ny for­mer­ly known as Ada­gio has run in­to an­oth­er speed bump.

In­vivyd, which re­brand­ed last month in an at­tempt to shed its trou­bled rep­u­ta­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times